US Stock MarketDetailed Quotes
INFI Infinity Pharmaceuticals
- 0.008
- 0.0000.00%
15min DelayTrading Oct 3 16:00 ET
726.09KMarket Cap-17P/E (TTM)
0.000High0.000Low0Volume0.000Open0.008Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)90.76MShares0.18652wk High-0.02P/B715.88KFloat Cap0.00852wk Low--Dividend TTM89.49MShs Float104.000Historical High--Div YieldTTM0.00%Amplitude0.008Historical Low--Avg Price1Lot Size
Infinity Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | (Q3)Sep 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 24.43%-8.01M | 7.09%-12.58M | -4.46%-42.43M | 8.42%-8.9M | -19.58%-9.4M | -10.73%-10.6M | -0.48%-13.54M | -13.65%-40.62M | -14.20%-9.72M | 0.27%-7.86M |
| Net income from continuing operations | 16.94%-9.96M | 11.19%-11.05M | 1.97%-44.37M | 20.78%-9.23M | -0.04%-10.72M | -6.36%-11.99M | -6.94%-12.44M | -11.78%-45.26M | -9.93%-11.65M | -12.37%-10.71M |
| Depreciation and amortization | -11.67%106K | -13.22%105K | -4.58%458K | -11.67%106K | -8.26%111K | 0.00%120K | 1.68%121K | -0.62%480K | 0.84%120K | -0.82%121K |
| Other non cash items | 1.13%-263K | -96.50%-562K | -47.92%-1.1M | -192.77%-243K | -18.99%-307K | -18.22%-266K | -59.78%-286K | -152.13%-745K | -150.92%-83K | -153.53%-258K |
| Change In working capital | 73.13%1.25M | -58.13%-2.85M | -146.93%-1.04M | -147.27%-555K | -73.16%595K | -36.33%722K | 22.07%-1.8M | 59.86%2.21M | -17.03%1.17M | 215.36%2.22M |
| -Change in prepaid assets | 1,059.26%518K | 62.99%-581K | -443.27%-587K | 34.67%369K | 51.82%668K | -159.34%-54K | -147.63%-1.57M | -70.77%171K | -2.84%274K | 1,529.63%440K |
| -Change in payables and accrued expense | -4.93%772K | -1,036.22%-2.23M | -113.78%-300K | -189.37%-883K | -101.88%-33K | -24.47%812K | 88.09%-196K | 146.83%2.18M | -18.62%988K | 206.62%1.76M |
| -Change in other current assets | 15.56%104K | 14.94%100K | 3.38%367K | 29.73%96K | -11.32%94K | -2.17%90K | 4.82%87K | 19.13%355K | 10.45%74K | 9.28%106K |
| -Change in other current liabilities | -14.29%-144K | -14.75%-140K | -6.13%-519K | 15.43%-137K | -50.56%-134K | -1.61%-126K | -7.02%-122K | -28.68%-489K | -9.46%-162K | -1,880.00%-89K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 24.43%-8.01M | 7.09%-12.58M | -4.46%-42.43M | 8.42%-8.9M | -19.58%-9.4M | -10.73%-10.6M | -0.48%-13.54M | -13.65%-40.62M | -14.20%-9.72M | 0.27%-7.86M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | -101.00%-55K | 0 | 97,654.55%10.73M | 3.28M | -355.75%-14.07M | -62.48%5.49M | 0 | 99.88%-11K |
| Net PPE purchase and sale | --0 | --0 | -54.55%-17K | --0 | --0 | --0 | ---17K | 74.42%-11K | --0 | ---11K |
| Net investment purchase and sale | --0 | --0 | -100.69%-38K | --0 | --10.73M | --3.28M | -355.44%-14.05M | -62.52%5.5M | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | -101.00%-55K | --0 | 97,654.55%10.73M | --3.28M | -355.75%-14.07M | -62.48%5.49M | --0 | 99.88%-11K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -99.92%73K | -91.29%31K | -97.44%14K | 217.43%87.11M | -73.75%356K | -91.58%546K | ||||
| Net common stock issuance | ---- | ---- | -99.92%73K | -91.29%31K | -97.44%14K | ---- | ---- | 1,006.94%87.11M | -73.75%356K | -91.58%546K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | ---- | ---- | -99.92%73K | -91.29%31K | -97.44%14K | ---- | ---- | 217.43%87.11M | -73.75%356K | -91.58%546K |
| Net cash flow | ||||||||||
| Beginning cash position | -51.40%25.9M | -52.44%38.47M | 179.80%80.88M | -47.54%47.34M | -52.86%46M | -50.24%53.28M | 179.80%80.88M | 28.05%28.91M | 378.94%90.25M | 233.74%97.57M |
| Current changes in cash | -9.66%-7.99M | 54.44%-12.58M | -181.60%-42.41M | 5.27%-8.87M | 118.34%1.34M | 23.28%-7.29M | -135.31%-27.6M | 720.72%51.98M | -193.02%-9.36M | 29.50%-7.33M |
| End cash Position | -61.07%17.9M | -51.40%25.9M | -52.44%38.47M | -52.44%38.47M | -47.54%47.34M | -52.86%46M | -50.24%53.28M | 179.80%80.88M | 179.80%80.88M | 378.94%90.25M |
| Free cash flow | 24.43%-8.01M | 7.20%-12.58M | -4.48%-42.45M | 8.42%-8.9M | -19.41%-9.4M | -10.73%-10.6M | -0.61%-13.55M | -13.55%-40.63M | -14.21%-9.72M | 0.13%-7.87M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg